[HTML][HTML] PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Background Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
[PDF][PDF] PDXGEM: Patient-Derived Tumor Xenograft based Gene Expression Model for Predicting Clinical Response to Anticancer Therapy in Cancer Patients
Y Kim, D Kim, B Cao, R Carvajal, M Kim - scholar.archive.org
Background: Cancer is a highly heterogeneous disease and shows varying responses to
anti-cancer drugs. Although several approaches have been attempted to predict the drug …
anti-cancer drugs. Although several approaches have been attempted to predict the drug …
[HTML][HTML] PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Y Kim, D Kim, B Cao, R Carvajal… - BMC …, 2020 - bmcbioinformatics.biomedcentral …
Cancer is a highly heterogeneous disease with varying responses to anti-cancer drugs.
Although several attempts have been made to predict the anti-cancer therapeutic responses …
Although several attempts have been made to predict the anti-cancer therapeutic responses …
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Y Kim, D Kim, B Cao, R Carvajal, M Kim - BMC Bioinformatics, 2020 - search.proquest.com
Background Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
PDXGEM: Patient-Derived Tumor Xenograft based Gene Expression Model for Predicting Clinical Response to Anticancer Therapy in Cancer Patients
Y Kim, D Kim, B Cao, R Carvajal, M Kim - bioRxiv, 2019 - biorxiv.org
Background Cancer is a highly heterogeneous disease and shows varying responses to anti-
cancer drugs. Although several approaches have been attempted to predict the drug …
cancer drugs. Although several approaches have been attempted to predict the drug …
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Y Kim, D Kim, B Cao, R Carvajal, M Kim - 2020 - agris.fao.org
Background Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
[HTML][HTML] PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Y Kim, D Kim, B Cao, R Carvajal, M Kim - BMC Bioinformatics, 2020 - ncbi.nlm.nih.gov
Background Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
Y Kim, D Kim, B Cao, R Carvajal, M Kim - BMC Bioinformatics, 2020 - europepmc.org
BACKGROUND: Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Y Kim, D Kim, B Cao, R Carvajal… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
Y Kim, D Kim, B Cao, R Carvajal… - BMC Bioinformatics, 2020 - search.ebscohost.com
Background: Cancer is a highly heterogeneous disease with varying responses to anti-
cancer drugs. Although several attempts have been made to predict the anti-cancer …
cancer drugs. Although several attempts have been made to predict the anti-cancer …